1. Introduction

Liability for AI-generated biological harm refers to the legal responsibility arising when an artificial intelligence system creates, designs, recommends, modifies, or facilitates biological processes or products that cause injury to human beings, animals, plants, or the environment.

Artificial intelligence is increasingly being applied in:

Genetic engineering and genome editing.

Synthetic biology and DNA sequencing.

Drug discovery and biological experimentation.

Development of microorganisms and engineered viruses.

Automated laboratory operations.

AI-assisted medical diagnosis and treatment.

Agricultural biotechnology and genetically modified organisms.

Although these technologies can provide significant benefits, they may also create serious biological risks. An AI system might generate an unsafe genetic sequence, recommend an incorrect biological procedure, design a harmful microorganism, or operate laboratory equipment in a manner that causes contamination.

The central legal question is:

Who should be held liable when biological harm results from an AI-generated design or decision?

Potentially responsible parties include:

AI developers and software companies.

Biotechnology companies.

Pharmaceutical manufacturers.

Laboratory owners and operators.

Researchers and scientists.

Hospitals and medical professionals.

Organizations deploying AI systems.

Persons intentionally misusing AI-generated biological information.

An important distinction is that AI-generated biological harm is an emerging legal category. There is no established body of reported court decisions specifically determining liability for AI-generated biological injuries. Therefore, conventional principles of negligence, product liability, medical malpractice, environmental law, constitutional law, and criminal responsibility must be applied by analogy.

The following discussion primarily considers Indian law, with relevant international case law.

2. Meaning and Nature of AI-Generated Biological Harm

AI-generated biological harm occurs when an AI system contributes to the creation or release of a biological agent, substance, process, or intervention that causes legally recognizable damage.

Examples include:

A. Genetic harm

An AI-generated genetic modification may produce unintended mutations, hereditary abnormalities, or other harmful biological consequences.

B. Microbiological harm

An AI-designed microorganism may escape laboratory containment and cause infection or environmental contamination.

C. Medical harm

An AI-generated treatment recommendation may result in incorrect medication, inappropriate gene therapy, or an unsafe medical intervention.

D. Pharmaceutical harm

An AI system may recommend an unsafe drug composition or fail to identify dangerous biological interactions.

E. Ecological harm

AI-designed organisms may disturb ecosystems, damage biodiversity, or affect agricultural species.

F. Laboratory automation harm

An autonomous laboratory system may execute an unsafe experiment, mishandle biological materials, or fail to follow containment protocols.

The law must distinguish between accidental technological failure, negligent deployment, defective products, and deliberate biological misuse.

3. Essential Legal Principles Governing Liability

A. Principle of negligence

Negligence arises when a person or organization fails to exercise the legally required standard of reasonable care and that failure causes foreseeable injury.

In AI-generated biological harm, negligence may arise when:

Developers fail to test an AI system adequately.

Researchers rely on AI-generated biological instructions without verification.

Laboratories fail to implement appropriate containment measures.

Manufacturers release unsafe biological products.

Hospitals use AI recommendations without appropriate clinical supervision.

The claimant generally needs to establish duty of care, breach, causation, and damage.

B. Product liability

Where an AI-enabled biological product is defective, the manufacturer, product seller, or other legally responsible party may face product liability.

Under the Consumer Protection Act, 2019, relevant provisions include:

Section 2(34): Product liability.

Section 2(36): Product liability action.

Section 82: Application of product liability provisions.

Section 83: Product liability action.

Section 84: Liability of product manufacturer.

Section 85: Liability of product service provider.

Section 86: Liability of product seller.

For example, if an AI-enabled medical device generates an unsafe biological treatment recommendation because of a design defect, liability may arise depending on the statutory definitions, the nature of the product or service, and the facts.

C. Strict liability

Strict liability may apply where a person brings a dangerous substance or activity onto land and it escapes, causing damage, subject to the recognized exceptions.

This principle is particularly relevant to laboratories and biotechnology facilities handling dangerous biological materials.

D. Absolute liability

Indian environmental jurisprudence recognizes a stronger principle of absolute liability for enterprises engaged in hazardous or inherently dangerous activities.

An enterprise cannot avoid liability merely by establishing that it exercised reasonable care.

This principle may be relevant where AI-assisted biotechnology operations involve hazardous biological substances or processes.

E. Criminal liability

Criminal liability may arise when biological harm results from conduct satisfying the requirements of an applicable criminal offence.

Depending on the facts, this may involve:

Rash or negligent acts causing death or injury.

Intentional administration of harmful substances.

Criminal misappropriation or misuse of biological materials.

Destruction of property or environmental offences.

Deliberate biological attacks.

The mere fact that an AI system produced a harmful output does not automatically establish criminal liability against its developer.

4. Liability of Different Persons Involved in AI-Generated Biological Harm

A. Liability of AI developers

AI developers may be held responsible when biological harm results from defects in the design, programming, testing, or safety architecture of an AI system.

Examples:

Developing an AI model that generates biologically dangerous genetic sequences without adequate safeguards.

Failing to identify foreseeable risks associated with AI-generated biological recommendations.

Providing an unreliable system for use in high-risk biotechnology laboratories.

Failing to disclose known limitations of a biological AI model.

Legal basis: Negligence, product liability where applicable, and ordinary principles of tort law.

However, developers are not automatically liable for every harmful use of their systems. Courts would examine foreseeability, the developer's role, reasonable safety precautions, the user's conduct, and the causal connection with the injury.

B. Liability of biotechnology companies

Biotechnology companies may be liable when they use AI-generated biological designs in manufacturing, experimentation, or commercial applications without adequate safety verification.

For example, a biotechnology company uses an AI-generated genetic modification to develop a commercial organism. The organism subsequently causes environmental damage or human illness.

The company may be responsible for:

Failure to conduct biological safety assessments.

Failure to obtain necessary regulatory approvals.

Improper containment of genetically engineered organisms.

Failure to conduct adequate testing.

Negligent commercial release of dangerous biological products.

C. Liability of researchers and scientists

Researchers cannot necessarily escape liability by claiming that they followed instructions generated by artificial intelligence.

A researcher who knowingly uses an unsafe AI-generated biological procedure without appropriate verification may be liable for negligence.

Professional responsibility requires researchers to exercise independent scientific judgment and follow applicable biosafety requirements.

D. Liability of laboratory operators

Laboratories have an important responsibility to ensure that AI-generated biological instructions are implemented safely.

Liability may arise from:

Inadequate laboratory containment.

Improper disposal of biological materials.

Failure to supervise automated equipment.

Failure to maintain safety protocols.

Negligent handling of genetically modified organisms.

E. Liability of hospitals and medical institutions

Hospitals may face liability when they use AI-generated biological or medical recommendations without appropriate professional supervision.

For example, an AI system recommends a gene therapy treatment that is unsuitable for a patient. A hospital administers it without proper clinical evaluation, resulting in permanent injury.

Depending on the facts, liability may arise from medical negligence, deficiency in service, lack of informed consent, or institutional negligence.

F. Liability of the user who misuses AI

A person who intentionally employs AI-generated biological information to cause injury may face civil and criminal liability.

For instance, a person deliberately uses AI-generated biological instructions to contaminate a water supply or expose individuals to a harmful microorganism.

The person's responsibility would arise from their own unlawful conduct, not merely from the AI system's involvement.

5. Important Indian Statutory Provisions

Several Indian statutes can apply to AI-generated biological harm.

A. Article 21 – Right to life

Article 21 protects life and personal liberty.

The constitutional protection of life has been interpreted to include important dimensions of health, human dignity, and environmental protection.

If an AI-assisted biological experiment results in widespread contamination or serious injury, affected individuals may seek constitutional remedies where the requirements for public-law intervention are satisfied.

B. Environment (Protection) Act, 1986

This Act is particularly important because AI-assisted biotechnology may involve genetically engineered organisms and hazardous microorganisms.

Sections 3 and 5 empower the Central Government to take environmental protection measures and issue directions.

Section 15 provides the penalty framework for contraventions, subject to the applicable statutory amendments.

C. Rules of 1989 concerning genetically engineered organisms

The Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Micro-organisms/Genetically Engineered Organisms or Cells, 1989 are especially relevant.

They regulate activities involving:

Hazardous microorganisms.

Genetically engineered organisms.

Genetically engineered cells.

Manufacture and storage of regulated biological materials.

Research and commercial applications involving genetic engineering.

The regulatory framework includes the Institutional Biosafety Committee (IBSC), Review Committee on Genetic Manipulation (RCGM), Genetic Engineering Appraisal Committee (GEAC), State Biotechnology Coordination Committees and District Level Committees.

These regulatory requirements are not displaced merely because an AI system designed or recommended the biological intervention.

ibkp.dbt.gov.in+3

D. Consumer Protection Act, 2019

The Consumer Protection Act may provide remedies where defective AI-enabled products or deficient services cause harm to consumers.

Important provisions include:

Section 83: Product liability action.

Section 84: Liability of product manufacturer.

Section 85: Liability of product service provider.

Section 86: Liability of product seller.

Section 87: Exceptions to product liability actions.

A claimant must establish the relevant statutory requirements. The mere presence of AI in a product does not automatically establish product liability.

6. Important Case Laws Relating to AI-Generated Biological Harm

The following judgments provide important legal foundations. They are not direct decisions on AI-generated biological harm; rather, they establish principles that can be applied to such disputes.

Case 1. M.C. Mehta v. Union of India (1987)

Citation: (1987) 1 SCC 395.

Court: Supreme Court of India.

Facts:

The case arose from the leakage of oleum gas from Shriram Food and Fertilizers Industries in Delhi. The gas leakage caused injury and raised important questions concerning the responsibility of enterprises engaged in hazardous industrial activities.

Judgment:

The Supreme Court developed the principle of absolute liability.

The Court held that an enterprise engaged in hazardous or inherently dangerous activities owes an absolute and non-delegable duty to the community.

Where harm results from such activities, the enterprise must compensate the affected persons.

The enterprise cannot escape liability by arguing that it exercised reasonable care.

Relevance to AI-generated biological harm:

Suppose a biotechnology company uses an AI system to develop a hazardous microorganism. Due to unsafe laboratory operations, the organism escapes and infects surrounding communities.

Under the principle of absolute liability, the enterprise conducting the hazardous activity may be required to compensate victims.

The company cannot necessarily avoid responsibility by arguing that the AI system generated the unsafe biological design.

Legal principle: Enterprises conducting hazardous activities bear an absolute duty to prevent harm.

ELAW: Environmental Law Alliance Worldwide+1

Case 2. Indian Council for Enviro-Legal Action v. Union of India (1996)

Citation: (1996) 3 SCC 212.

Court: Supreme Court of India.

Facts:

Chemical industries in Rajasthan caused environmental contamination through the discharge of hazardous substances.

The pollution affected agricultural land, soil, and groundwater.

Judgment:

The Supreme Court applied the principle of absolute liability and emphasized that industries responsible for environmental pollution must bear the costs of restoring environmental damage.

The Court recognized that the cost of pollution control and environmental restoration should not be transferred to innocent members of society.

Relevance to AI-generated biological harm:

Suppose an AI-designed organism escapes from an industrial biotechnology facility and damages agricultural biodiversity.

The responsible enterprise may be required to:

Compensate affected farmers.

Restore contaminated land.

Rehabilitate damaged ecosystems.

Bear the costs of environmental remediation.

The fact that the organism was generated using AI does not automatically eliminate the enterprise's responsibility.

Legal principle: The polluter must bear the financial consequences of environmental damage.

Indian Kanoon+1

Case 3. Vellore Citizens Welfare Forum v. Union of India (1996)

Citation: (1996) 5 SCC 647.

Court: Supreme Court of India.

Facts:

Industrial pollution caused serious environmental degradation in areas affected by tannery operations in Tamil Nadu.

Untreated industrial effluents polluted agricultural land and water resources.

Judgment:

The Supreme Court recognized two major environmental principles:

Precautionary Principle.

Polluter Pays Principle.

The Court held that environmental protection authorities must anticipate and prevent environmental degradation.

It further held that scientific uncertainty should not prevent preventive measures where there is a threat of serious or irreversible damage.

Relevance to AI-generated biological harm:

AI-generated biological interventions may produce consequences that cannot be predicted with complete scientific certainty.

For example, an AI-designed genetically modified organism may have unknown long-term effects on biodiversity.

Under the precautionary principle, regulators may require safety assessments and preventive restrictions even before actual environmental injury occurs.

Legal principle: Lack of complete scientific certainty is not a justification for ignoring serious environmental risks.

Indian Kanoon+1

Case 4. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

Citation: (1999) 2 SCC 718.

Court: Supreme Court of India.

Facts:

The case concerned environmental protection and the assessment of risks associated with potentially polluting industrial activities.

The Court considered the importance of scientific expertise in environmental decision-making.

Judgment:

The Supreme Court emphasized the importance of the precautionary principle and recognized the difficulties of making environmental decisions where scientific uncertainty exists.

The Court highlighted the need for expert scientific assessment in environmental disputes.

Relevance to AI-generated biological harm:

AI-generated biological systems may involve highly technical risks that ordinary legal evidence cannot easily explain.

Courts may need assistance from:

Genetic scientists.

Microbiologists.

Bioinformatics experts.

AI specialists.

Environmental scientists.

The judgment supports the importance of scientific expertise in assessing uncertain biological risks.

Legal principle: Scientific uncertainty and technical complexity require informed precautionary decision-making.

Indian Kanoon+1

Case 5. Jacob Mathew v. State of Punjab (2005)

Citation: (2005) 6 SCC 1.

Court: Supreme Court of India.

Facts:

The case concerned allegations of medical negligence following the death of a patient in a hospital.

The Supreme Court examined the standard required to establish criminal medical negligence.

Judgment:

The Court explained that criminal negligence requires a sufficiently high degree of negligence.

A mere error of judgment or ordinary negligence does not automatically constitute criminal negligence.

The Court discussed the professional standard of care applicable to medical practitioners.

Relevance to AI-generated biological harm:

Suppose a doctor uses an AI-based genetic treatment recommendation that results in serious injury.

The doctor cannot automatically avoid responsibility by arguing that the AI system produced the recommendation.

However, criminal liability must be assessed according to the applicable statutory offence and the required degree of negligence.

The distinction between civil negligence and criminal negligence is particularly important.

Legal principle: Professional negligence must be evaluated against the applicable standard of reasonable professional care; criminal liability requires the relevant criminal threshold.

Indian Kanoon

Case 6. Samira Kohli v. Dr. Prabha Manchanda (2008)

Citation: (2008) 2 SCC 1.

Court: Supreme Court of India.

Facts:

The patient consented to a diagnostic procedure. However, while she was under anaesthesia, the doctor performed a more extensive operation without obtaining the required consent.

Judgment:

The Supreme Court emphasized the importance of informed consent.

Consent to one medical procedure does not automatically authorize a substantially different procedure.

The patient's right to decide what happens to their body must be respected.

Relevance to AI-generated biological harm:

Suppose a hospital uses AI to recommend genetic modification or an experimental biological treatment.

The hospital must obtain legally valid consent where required.

It cannot argue that the AI system recommended the procedure or that the procedure was technologically beneficial as a substitute for valid consent.

Legal principle: AI-assisted medical intervention does not remove the obligation to obtain valid informed consent.

Indian Kanoon+1

Case 7. Spring Meadows Hospital v. Harjol Ahluwalia (1998)

Citation: (1998) 4 SCC 39.

Court: Supreme Court of India.

Facts:

A child suffered serious injury following negligent medical treatment at a hospital. The dispute involved the responsibility of medical professionals and the hospital.

Judgment:

The Supreme Court recognized the liability of medical institutions for deficiencies in medical services and addressed the responsibility of hospitals for negligent acts of their employees.

Relevance to AI-generated biological harm:

If a hospital deploys an AI-powered biological diagnostic system and its employees negligently rely on an unsafe recommendation, the hospital may face liability.

The institution cannot necessarily avoid responsibility by claiming that the error originated in an external technological system.

Legal principle: Medical institutions may be held responsible for negligence and deficiencies in services provided through their organizational structure.

Case 8. Donoghue v. Stevenson (1932)

Citation: [1932] AC 562.

Court: House of Lords, United Kingdom.

Facts:

A consumer became ill after consuming ginger beer containing a decomposed snail.

The consumer had not purchased the product directly from the manufacturer.

Judgment:

The House of Lords established the modern neighbour principle.

A manufacturer owes a duty of care to persons who may reasonably be affected by defective products.

Relevance to AI-generated biological harm:

A company developing AI-powered biological products may owe duties of care to foreseeable end users and potentially affected third parties.

For example, an AI-generated pharmaceutical product containing an unsafe biological component may injure a patient who has no direct contractual relationship with the AI developer.

The case supports the development of manufacturer responsibility even where contractual relationships are absent.

Legal principle: A duty of care may arise towards persons foreseeably affected by a defective product.

Case 9. Rylands v. Fletcher (1868)

Citation: (1868) LR 3 HL 330.

Court: House of Lords, United Kingdom.

Facts:

The defendant constructed a reservoir on his land. Water escaped through underground passages and flooded the plaintiff's mine.

Judgment:

The Court established the rule that a person who brings onto land and accumulates something likely to cause harm if it escapes may be strictly liable for the resulting damage, subject to recognized exceptions.

Relevance to AI-generated biological harm:

Suppose an organization stores AI-designed hazardous microorganisms in a biological laboratory. These organisms escape and contaminate surrounding property.

The principle may support strict liability, subject to the requirements and exceptions of the rule.

In India, however, the stronger absolute-liability principle in the Oleum Gas Leak Case applies to qualifying hazardous enterprises.

Legal principle: Escape of a dangerous substance from a controlled premises may give rise to strict liability.

Case 10. Bolam v. Friern Hospital Management Committee (1957)

Citation: [1957] 1 WLR 582.

Court: Queen's Bench Division, United Kingdom.

Facts:

The case involved allegations of negligence against a hospital concerning the treatment provided to a patient undergoing electroconvulsive therapy.

Judgment:

The Court considered whether the medical professional had acted in accordance with a practice accepted as proper by a responsible body of medical professionals.

This became known as the Bolam test.

Relevance to AI-generated biological harm:

Where a doctor uses an AI-based biological diagnostic or treatment system, the standard of professional care may require examination of accepted medical practice, the reliability of the technology, and the need for independent clinical judgment.

A doctor should not blindly rely on an AI recommendation simply because the software is widely used.

Legal principle: Professional negligence is assessed against the applicable standard of competent professional practice.

7. How Causation Is Established in AI-Generated Biological Harm

Causation is one of the most difficult issues in these cases.

A claimant must establish that the defendant's legally relevant conduct caused or materially contributed to the biological injury.

Consider this hypothetical situation:

An AI system generates a genetic modification. A biotechnology company adopts the modification, manufactures a genetically engineered organism, and releases it into the environment. The organism causes damage to agricultural crops.

The claimant must establish the connection between:

The AI-generated biological design.

The company's decision to use that design.

The manufacture and release of the organism.

The biological or environmental injury.

The legally attributable conduct of the defendant.

Important causation questions

A. Factual causation

Would the biological harm have occurred without the defendant's conduct?

B. Foreseeability

Could a reasonable developer, researcher, or biotechnology company have anticipated the relevant risk?

C. Intervening acts

Did an independent act, such as deliberate sabotage or unauthorized modification, break the chain of legal causation?

D. Scientific evidence

Can genetic sequencing, laboratory records, biological testing, and other scientific evidence connect the AI-generated design with the injury?

E. Multiple responsible parties

Did the harm result from the combined conduct of the developer, laboratory operator, manufacturer, and user?

A court may have to apportion responsibility according to the applicable legal principles and the evidence.

8. Liability When AI Generates an Unexpected Biological Result

One of the most complicated situations arises when an AI system produces a biological result that its developer did not specifically anticipate.

For example:

An AI system is developed to identify beneficial genetic modifications. However, it generates an unexpected modification that causes an organism to develop harmful characteristics.

Three legal situations may arise.

An unexpected result does not automatically establish negligence.

The court must examine whether the risk was reasonably foreseeable, whether appropriate safeguards were adopted, and whether the applicable legal requirements were breached.

9. Criminal Liability for AI-Generated Biological Harm

Criminal liability becomes relevant when AI-assisted biological activities result in conduct constituting an offence.

Under the Bharatiya Nyaya Sanhita, 2023:

Section 106 – Causing death by negligence

Where the ingredients of the offence are established, a person responsible for a negligent act causing death may face criminal liability.

Section 125 – Act endangering life or personal safety of others

This provision addresses rash or negligent acts that endanger human life or personal safety and cause the specified forms of injury.

Other criminal provisions may become relevant depending on whether the conduct involves intentional poisoning, grievous injury, unlawful confinement, or other offences.

Can AI itself be criminally liable?

Under the present Indian legal framework, AI systems are not recognized as independent criminal persons.

Therefore, criminal responsibility ordinarily has to be attributed to legally recognized persons, subject to the elements of the particular offence.

Potentially responsible persons may include:

Individuals who intentionally misuse the AI system.

Researchers who knowingly violate safety requirements.

Responsible laboratory personnel.

Corporate officers where the applicable law establishes their responsibility.

Organizations where statutory provisions permit corporate criminal attribution.

Important distinction: A developer is not automatically criminally responsible merely because an AI system generated an unsafe biological output. The prosecution must establish the required elements of the particular offence and the defendant's legally attributable conduct.

10. Constitutional Liability and the Right to Biological Safety

AI-generated biological harm may also raise constitutional questions.

Article 21

Article 21 protects life and personal liberty.

Where AI-assisted biological activities cause serious threats to human life, public health, or bodily integrity, affected persons may seek appropriate constitutional remedies.

Article 14

Article 14 guarantees equality before the law and equal protection of the laws.

If public authorities deploy AI-based biological technologies arbitrarily or discriminate in access to biological healthcare, constitutional scrutiny may arise.

Article 32 and Article 226

These provisions provide constitutional remedies through the Supreme Court and High Courts respectively.

For example, a public-interest petition may seek judicial intervention where a government-authorized biotechnology project creates a substantial and inadequately regulated threat to public health or the environment.

However, constitutional remedies are not a substitute for every private damages claim. The nature of the defendant, the alleged violation, and the appropriate remedy must be examined.

11. Defences Available to Defendants

A defendant facing a claim for AI-generated biological harm may raise several legal defences.

A. Absence of negligence

The developer may establish that reasonable precautions, testing, and safety mechanisms were adopted.

B. Independent misuse by a third party

A developer may argue that an independent person deliberately misused the system in a manner that was not reasonably foreseeable.

Whether this defence succeeds depends on causation and foreseeability.

C. Regulatory compliance

A company may establish that it complied with applicable biosafety regulations and obtained the necessary approvals.

However, regulatory compliance does not automatically eliminate civil liability, particularly under absolute liability principles.

D. Lack of causation

The defendant may argue that the biological injury resulted from an independent cause rather than the AI-generated design.

E. Contributory negligence

Where legally applicable, the defendant may argue that the claimant's own negligent conduct contributed to the injury.

F. Development risks

A defendant may argue that the biological risk could not reasonably have been discovered using the scientific knowledge available at the relevant time.

The availability of this defence depends on the applicable statutory or common-law regime. It is not a universal defence to negligence or India's absolute liability principle.

12. Remedies Available to Victims

Victims of AI-generated biological harm may seek different forms of legal relief.

In particularly serious cases, courts may also consider interim protective measures, including restrictions on further releases of dangerous biological materials.

13. International Legal Perspective

AI-generated biological harm is not exclusively an Indian legal concern.

Several international frameworks are relevant.

A. Cartagena Protocol on Biosafety, 2000

The Protocol addresses the safe handling, transfer, and use of living modified organisms resulting from modern biotechnology.

It is particularly relevant to cross-border movement and environmental risks associated with genetically modified organisms.

B. Nagoya–Kuala Lumpur Supplementary Protocol on Liability and Redress, 2010

This instrument addresses response measures and liability-related questions concerning damage resulting from living modified organisms within its scope.

C. European Union Product Liability Directive

Directive (EU) 2024/2853 modernizes product liability rules and expressly includes software, including AI systems, within its product framework.

Its provisions are relevant to defective AI-enabled products, including products that incorporate AI-generated biological technologies.

Its application is subject to the Directive's territorial, temporal, and substantive requirements; it does not automatically govern Indian disputes.

ibkp.dbt.gov.in+2

14. Hypothetical Judicial Analysis

Consider the following hypothetical case.

Facts:

A biotechnology company develops an AI-powered genetic engineering system. The system generates a genetic modification that produces an organism with unexpected harmful biological characteristics.

The company uses the design without adequate testing. The organism is subsequently released into the environment, damaging agricultural crops and causing illness among nearby residents.

Possible judicial analysis:

The court examines whether the company was engaged in a hazardous or inherently dangerous activity.

It determines whether the company complied with the 1989 Biosafety Rules and other applicable regulations.

It examines whether adequate biological risk assessments were undertaken.

It determines whether the AI-generated design was causally connected with the resulting harm.

It considers whether absolute liability applies under M.C. Mehta v. Union of India.

It considers environmental restoration and compensation under the principles recognized in Vellore Citizens Welfare Forum and Indian Council for Enviro-Legal Action.

It examines whether the developer or other participants independently breached a duty of care.

It determines whether any criminal offence has been established against an identifiable person or legally responsible entity.

Possible outcome: The biotechnology enterprise may be held liable under the absolute liability principle if the requirements for its application are satisfied. Other parties may also face liability depending on their respective involvement and the evidence.

This is an illustrative application of existing legal principles, not an actual reported judgment.

15. Challenges in Determining Liability for AI-Generated Biological Harm

Several difficulties arise when courts attempt to apply traditional law to AI-assisted biological technologies.

1. Identification of the responsible party: Multiple participants may contribute to a single biological injury.

2. Black-box AI systems: It may be difficult to explain precisely how an AI model generated a particular biological recommendation.

3. Scientific uncertainty: Biological consequences may become apparent only after a considerable period.

4. Difficulty proving causation: Genetic mutations and biological interactions may have multiple possible causes.

5. Cross-border liability: Developers, laboratories, manufacturers, and victims may be situated in different countries.

6. Lack of AI-specific legislation: Existing Indian laws regulate biological activities and recognize general principles of liability, but do not comprehensively allocate responsibility for AI-generated biological harm.

7. Evidence preservation: AI prompts, model versions, training records, output histories, laboratory logs, and biological samples may be essential to determining responsibility.

16. Suggestions for Legal and Regulatory Reforms

India could strengthen its legal framework through the following measures:

Mandatory risk assessments for high-risk AI-assisted biological research.

Independent verification of AI-generated genetic and microbiological designs.

Clear legal responsibilities for AI developers, biotechnology companies, and laboratory operators.

Mandatory incident reporting for serious AI-associated biological accidents.

Appropriate insurance and financial security for high-risk biotechnology enterprises.

Preservation of AI-generated records and laboratory evidence.

Stronger monitoring of biological containment facilities.

Clear procedures for compensating victims of AI-associated biological injuries.

International cooperation concerning cross-border biological risks.

Appropriate safeguards for autonomous laboratory systems.

These reforms could make the legal allocation of responsibility more predictable without treating AI systems themselves as independent legal persons.

17. Conclusion

Liability for AI-generated biological harm represents an emerging intersection of artificial intelligence law, biotechnology law, environmental law, medical negligence, and product liability.

The most important legal issue is not simply whether artificial intelligence generated the harmful biological result, but whether identifiable individuals or organizations breached legal duties in designing, developing, testing, approving, deploying, or supervising the technology.

Indian courts can draw upon established principles of negligence, product liability, strict liability, absolute liability, informed consent, and environmental protection.

The judgments in M.C. Mehta v. Union of India, Indian Council for Enviro-Legal Action v. Union of India, Vellore Citizens Welfare Forum v. Union of India, and Jacob Mathew v. State of Punjab provide particularly important foundations.

The central legal proposition is that the use of artificial intelligence cannot, by itself, provide immunity from responsibility for biological harm. Responsibility must be determined according to the conduct of the relevant human and corporate actors, applicable statutory obligations, causation, and the nature of the harm.

18. Important Case Law Revision Table

Academic clarification: None of these judgments directly decides liability for AI-generated biological harm. They are established precedents whose legal principles may be applied to future disputes involving AI and biotechnology.

Suggested primary legal research sources

Department of Biotechnology – Biotechnology Rules and Guidelines

India Code – Central legislation

Supreme Court of India – Judgments

EU Product Liability Directive 2024/2853

For academic and examination purposes, distinguish between binding Indian statutory provisions and judicial precedents that are being applied by analogy to an emerging technological problem.